Achieve life sciences announces $20m loan refinancing with silicon valley bank

Seattle and vancouver, british columbia, july 29, 2024 (globe newswire) -- achieve life sciences, inc. (nasdaq: achv), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that it has entered into a $20 million debt refinancing agreement with silicon valley bank (svb), a division of first-citizens bank. the new loan agreement refinances the existing debt facility with svb and svb capital and extends the maturity date from august 1, 2024 to december 1, 2027.
ACHV Ratings Summary
ACHV Quant Ranking